"NZCR is a Medical Research Facility"

During the past decade, Auckland Clinical Studies conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 40 clinical trials were completed, i.e. on average, 29.2% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 26 clinical trials were completed. i.e. 32.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Auckland Clinical Studies" #1 sponsor was "Gilead Sciences" with 29 trials, followed by "Hoffmann-La Roche" with 17 trials sponsored, "Arrowhead Pharmaceuticals" with 12 trials sponsored, "Assembly Biosciences" with 8 trials sponsored and "Janssen Research & Development, LLC" with 8 trials sponsored. Other sponsors include 86 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Auckland Clinical Studies" #1 collaborator was "Iqvia Pty Ltd" with 3 trials as a collaborator, "Novotech (Australia) Pty Limited" with 3 trials as a collaborator, "Nippon Shinyaku Co., Ltd." with 2 trials as a collaborator, "Arbutus Biopharma Corporation" with 1 trials as a collaborator and "CuraTeQ Biologics Private Ltd." with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Auckland Clinical Studies" are "Chronic Hepatitis B" (19 trials), "Healthy Volunteers" (13 trials), "Healthy" (8 trials), "Hepatitis B, Chronic" (8 trials) and "Chronic Hepatitis C" (7 trials). Many other conditions were trialed in "Auckland Clinical Studies" in a lesser frequency.

Most popular intervention types in "Auckland Clinical Studies" are "Drug" (141 trials), "Other" (18 trials), "Biological" (17 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (54 trials), "RBV" (6 trials), "SOF" (5 trials), "TAF" (5 trials) and "ARO-APOC3" (4 trials). Other intervention names were less common.

The vast majority of trials in "Auckland Clinical Studies" are 145 trials for "All" genders, 14 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Auckland Clinical Studies". undefined are not yet recruiting, 26 are recruiting, 18 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 91 completed trials in Auckland Clinical Studies, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Auckland Clinical Studies, 89 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".

Auckland Clinical Studies has several departments that took part in Clinical trials: "Lipid and Diabetes Research Group" - 11 trials